Abstract
Introduction of bronchoscopic lung volume reduction as a treatment for severe emphysema has been defined as an area of development by The Danish Health and Medicines Authority. We here present the rationale for treatment, in- and exclusion criteria, and ultimately the organization for assessment, treatment and follow-up in Denmark. The treatment aim is to lower dyspnoea. There is a national protocol for patient selection according to in- and exclusion criteria. Different commercial devices are available, but endobronchial valves have been the devices mostly applied. A national database has been established to evaluate cost-effectiveness.
Translated title of the contribution | Bronchoscopic lung volume reduction is a treatment offered to patients with severe heterogenous emphysema. |
---|---|
Original language | Danish |
Article number | V01140005 |
Journal | Ugeskrift for Laeger |
Volume | 176 |
Issue number | 29 |
Pages (from-to) | 2-6 |
Number of pages | 5 |
ISSN | 0041-5782 |
Publication status | Published - 14 Jul 2014 |